Skip to main content
Clinical Trials/NCT02043470
NCT02043470CompletedNot Applicable

Changes in Regional Retinal Oxygen Extraction and Function After Radiation Therapy

UNC Lineberger Comprehensive Cancer Center1 site in 1 country32 target enrollmentStarted: March 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
32
Locations
1
Primary Endpoint
Abnormalities in regional retinal oxygen extraction after incidental irradiation of the retina.

Study Overview

Brief Summary

The investigators propose using retinal oximetry to assess for abnormalities in regional retinal oxygen consumption in previously- irradiated patients, and relate these abnormalities to changes in regional retinal function (i.e. visual field abnormalities). Since different regions of retina receive different radiation doses, the investigators will assess for a dose response as well.

Detailed Description

Radiation therapy (RT) is a common treatment for patients with cancers of the sinonasal area, orbit, skull base, nasopharynx, and brain. Because of the close proximity of these targets to the eyes, the retina is often incidentally and unavoidably irradiated. As a result, some patients develop radiation retinopathy and possibly vision loss. Clinicopathologic studies suggest similar microvascular mechanisms for both radiation- and diabetic retinopathy: small vessel occlusion and ischemia that can lead to neovascularization, increased capillary permeability, and visual loss in the regions of retina perfused by damaged vasculature. UNC has a novel, non-invasive retinal imaging technology called a Retinal Oximeter which measures hemoglobin oxygen saturation of retinal vessels. The difference in oxygen saturation between a retinal arteriole and venule pair reflects the oxygen consumption of the retinal region supplied by that vessel pair.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 99 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • ≥ 18 years of age at the time of radiation therapy (no upper age limit)
  • History of radiation therapy delivered at UNC-CH or Rex Hospital to the vicinity of the retina(s) ≥ 2 months prior to enrollment
  • Estimated average dose to at least one quadrant of one retina ≥ 30 Gy

Exclusion Criteria

  • History of diabetes, retinal vascular occlusions, glaucoma, retinitis pigmentosa, occipital stroke or any other ophthalmologic or systemic problem that may confound visual field results.
  • Residual tumor within the visual pathway: retina, optic nerves, optic chiasm, optic radiations and brain.

Outcomes

Primary Outcomes

Abnormalities in regional retinal oxygen extraction after incidental irradiation of the retina.

Time Frame: 2 months

To identify abnormalities in regional retinal oxygen extraction in patients who have had previous incidental irradiation of the retina.

Prevalence of vision loss in patients with previous incidental irradiation of the retina

Time Frame: 2 months

To determine the prevalence of regional retinal dysfunction (i.e. vision loss) in patients with previous incidental irradiation of the retina.

Secondary Outcomes

  • Vision loss amount versus radiation dose.(2 months)
  • Changes in retinal oxygen extraction as compared to vision loss.(2 months)
  • Changes in retinal oxygen extraction compared to radiation dose(2 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials